Unstable Composition of the Fecal Microbiota in Ulcerative Colitis During Clinical Remission
Abstract
BACKGROUND AND AIM: Studies have identified abnormal characteristics of the gut microbiota in patients with active IBD, but whether the changes are causal or secondary to inflammation remains uncertain. We investigated dynamics of fecal microbiota in ulcerative colitis (UC) during remission by genomic technology. PATIENTS AND METHODS: Patients in clinical remission and on stable maintenance mesalazine therapy were recruited (N = 33). Fecal samples were collected at regular intervals over a period of 1 yr. Sixteen patients who remained in remission and eight healthy controls were included in the analysis. Variable V6 to V8 regions of the 16S rRNA gene in DNA extracts from fecal samples were amplified by polymerase chain reaction. Amplicons were separated by denaturant gradient gel electrophoresis, band profiles were compared by software, and similarity indices were calculated from densitometric curves. RESULTS: Band profiles showed unique patterns with low similarity index between individuals, suggesting host specificity in the predominant microbiota. Within the same individual, profiles were stable in controls but varied notably over time in patients. In controls, the similarity index was remarkably stable (78 +/- 8% mean +/- SD) over a period of 24 months. However, patients showed a steady decline in similarity index versus the initial profile, dropping down to 42 +/- 24% at month 3 of follow-up and to 23 +/- 19% at month 12 (P < 0.001). Biodiversity of the dominant microbiota, as estimated by number of bands, was lower in patients (17 +/- 4) than controls (23 +/- 4, P < 0.01). CONCLUSION: Molecular analysis of fecal bacteria in patients with inactive UC shows low biodiversity and temporal instability.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
IBD is associated with decreased complexity in composition, with a loss of normal anaerobic bacteria, temporary composition instability during clinical remission, and dysbiosis towards selected microorganisms, with over- and under-representation of certain species.
“There is a decreased complexity in composition, with a loss of normal anaerobic bacteria [33] , a temporary composition instability during clinical remission [34] , and a dysbiosis towards selected microorganisms, with over-and under-representation of certain species [35] .”
From Intestinal microbiota in health and disease: Role of bifidobacteria in gut homeostasis (2014) · cites this paper as [34]
Cites
Muyzer, G., de Waal, E. C., & Uitterlinden, A. G. (1993) · Applied and Environmental Microbiology · doi:10.1128/aem.59.3.695-700.1993 · Cited by 11,455 · see citing works
Gut flora in health and disease
Guarner, F., & Malagelada, J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12489-0 · Cited by 3,395 · see citing works
Self-citationLoftus, E. V. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.01.063 · Cited by 3,115 · see citing works
Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach
Manichanh, C., Rigottier-Gois, L., Bonnaud, E., Gloux, K., Pelletier, E., Frangeul, L., Nalin, R., Jarrin, C., Chardon, P., Marteau, P., et al. (2006) · Gut · doi:10.1136/gut.2005.073817 · Cited by 2,277 · see citing works
Suau, A., Bonnet, R., Sutren, M., Godon, J.-J., Gibson, G. R., Collins, M. D., & Doré, J. (1999) · Applied and Environmental Microbiology · doi:10.1128/aem.65.11.4799-4807.1999 · Cited by 1,490 · see citing works
Zoetendal, E. G., Akkermans, A. D. L., & de Vos, W. M. (1998) · Applied and Environmental Microbiology · doi:10.1128/aem.64.10.3854-3859.1998 · Cited by 1,360 · see citing works
A simple clinical colitis activity index
Walmsley, R. S., Ayres, R., Pounder, R. E., & Allan, R. N. (1998) · Gut · doi:10.1136/gut.43.1.29 · Cited by 1,320 · see citing works
Ott, S. J., Musfeldt, M., Wenderoth, D. F., Hampe, J., Brant, O., Fölsch, U. R., Timmis, K. N., & Schreiber, S. (2004) · Gut · doi:10.1136/gut.2003.025403 · Cited by 1,311 · see citing works
Rapid silver staining and recovery of PCR products separated on polyacrylamide gels.
Cj, S., Neto, E. D., & Aj, S. (1994) · PubMed · Cited by 1,179 · see citing works
Sartor, R. B. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.03.024 · Cited by 1,053 · see citing works
Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon
Seksik, P., Rigottier‐Gois, L., Gramet, G., BRIEND‐SUTREN, M., Pochart, P., Marteau, P. R., Jian, R., & Dore, J. M. (2003) · Gut · doi:10.1136/gut.52.2.237 · Cited by 746 · see citing works
Tannock, G. W., Munro, K., Harmsen, H. J. M., Welling, G. W., Smart, J., & Gopal, P. K. (2000) · Applied and Environmental Microbiology · doi:10.1128/aem.66.6.2578-2588.2000 · Cited by 671 · see citing works
The Host Genotype Affects the Bacterial Community in the Human Gastronintestinal Tract
Zoetendal, A. D. L. A. E. G. (2001) · Microbial Ecology in Health and Disease · doi:10.1080/089106001750462669 · Cited by 558 · see citing works
Molecular Ecological Analysis of the Gastrointestinal Microbiota: A Review
Zoetendal, E. G., Collier, C. T., Koike, S., Mackie, R. I., & Gaskins, H. R. (2004) · Journal of Nutrition · doi:10.1093/jn/134.2.465 · Cited by 481 · see citing works
Specificities of the fecal microbiota in inflammatory bowel disease
Sokol, H., Seksik, P., Rigottier‐Gois, L., Lay, C., Lepage, P., Podglajen, I., Marteau, P. R., & Dore, J. M. (2006) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000200323.38139.c6 · Cited by 447 · see citing works
Inflammatory bowel disease: Immunodiagnostics, immunotherapeutics, and ecotherapeutics
Shanahan, F. (2001) · Gastroenterology · doi:10.1053/gast.2001.22122 · Cited by 371 · see citing works
Mechanisms of Disease: the hygiene hypothesis revisited
Guarner, F., Bourdet‐Sicard, R., Brandtzæg, P., Gill, H. S., McGuirk, P., van Eden, W., Versalovic, J. A., Weinstock, J. V., & Rook, G. A. W. (2006) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep0471 · Cited by 315 · see citing works
Self-citationMättö, J., Maunuksela, L., Kajander, K., Palva, A., Korpela, R., Kassinen, A., & Saarela, M. (2005) · FEMS Immunology & Medical Microbiology · doi:10.1016/j.femsim.2004.08.009 · Cited by 301 · see citing works
Recent understanding of IBD pathogenesis: Implications for future therapies
Kucharzik, T. F., Maaser, C., Lügering, A., Kagnoff, M. F., Mayer, L., Targan, S. R., & Domschke, W. (2006) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000235827.21778.d5 · Cited by 254 · see citing works
Halfvarson, J., Jess, T., Magnuson, A., Montgomery, S., Orholm, M. K., Tysk, C., Binder, V., & Järnerot, G. (2006) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000228998.29466.ac · Cited by 175 · see citing works
Review article: the role of bacteria in onset and perpetuation of inflammatory bowel disease
Seksik, P., Sokol, H., Lepage, P., Vasquez, N., Manichanh, C., Mangin, I., Pochart, P., Dore, J. M., & Marteau, P. R. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03053.x · Cited by 166 · see citing works
Gut flora and inflammatory bowel disease
Marteau, P. R., Lepage, P., Mangin, I., Suau, A., Dore, J. M., Pochart, P., & Seksik, P. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.02062.x · Cited by 128 · see citing works
van Nuenen, M. H. M. C., Venema, K., van der Woude, C. J., & Kuipers, E. J. (2004) · Digestive Diseases and Sciences · doi:10.1023/b:ddas.0000020508.64440.73 · Cited by 104 · see citing works
The intestinal flora in inflammatory bowel disease: normal or abnormal?
Guarner, F. (2005) · PubMed · Cited by 69 · see citing works
Self-citationVermeire, S. A. R. A. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03052.x · Cited by 63 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Byrd, A. L., Belkaid, Y., & Segre, J. A. (2018) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.157 · Cited by 2,806 · see citing works
Machiels, K., Joossens, M., Sabino, J., De Preter, V., Arijs, I., Eeckhaut, V., Ballet, V., Claes, K., Van Immerseel, F., Verbeke, K., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-304833 · Cited by 1,904 · see citing works
The Microbiome in Inflammatory Bowel Disease: Current Status and the Future Ahead
Kostic, A. D., Xavier, R. J., & Gevers, D. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.02.009 · Cited by 1,789 · see citing works
Inflammatory bowel disease: Pathogenesis
Zhang, Y.-Z. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i1.91 · Cited by 1,529 · see citing works
Gut microbiota in the pathogenesis of inflammatory bowel disease
Nishida, A., Inoüe, R., Inatomi, O., Bamba, S., Naito, Y., & Andoh, A. (2017) · Clinical Journal of Gastroenterology · doi:10.1007/s12328-017-0813-5 · Cited by 1,389 · see citing works
Dynamics of the human gut microbiome in inflammatory bowel disease
Halfvarson, J., Brislawn, C. J., Lamendella, R., Vázquez-Baeza, Y., Walters, W. A., Bramer, L. M., D'Amato, M., Bonfiglio, F., McDonald, D., Gonzalez, A., et al. (2017) · Nature Microbiology · doi:10.1038/nmicrobiol.2017.4 · Cited by 1,204 · see citing works
Manichanh, C., Borruel, N., Casellas, F., & Guarner, F. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.152 · Cited by 1,160 · see citing works
Self-citationChronic kidney disease alters intestinal microbial flora
Vaziri, N. D., Wong, J., Pahl, M., Piceno, Y. M., Yuan, J., DeSantis, T. Z., Ni, Z., Nguyen, T.-H., & Andersen, G. L. (2013) · Kidney International · doi:10.1038/ki.2012.345 · Cited by 1,164 · see citing works
Stress and stability: applying the Anna Karenina principle to animal microbiomes
Zaneveld, J. R., McMinds, R., & Vega Thurber, R. (2017) · Nature Microbiology · doi:10.1038/nmicrobiol.2017.121 · Cited by 977 · see citing works
Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases
Duboc, H., Rajca, S., Rainteau, D., Benarous, D., Maubert, M.-A., Quervain, E., Thomas, G., Barbu, V., Humbert, L., Despras, G., et al. (2013) · Gut · doi:10.1136/gutjnl-2012-302578 · Cited by 930 · see citing works
Guinane, C. M., & Cotter, P. D. (2013) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x13482996 · Cited by 846 · see citing works
The gut microbiota and inflammatory bowel disease
Matsuoka, K., & Kanai, T. (2015) · Seminars in Immunopathology · doi:10.1007/s00281-014-0454-4 · Cited by 804 · see citing works
Intestinal microbiota in human health and disease: the impact of probiotics
Gerritsen, J., Smidt, H., Rijkers, G. T., & de Vos, W. M. (2011) · Genes & Nutrition · doi:10.1007/s12263-011-0229-7 · Cited by 724 · see citing works
Walker, A. W., Sanderson, J. D., Churcher, C. M., Parkes, G. C., Hudspith, B. N., Rayment, N. B., Brostoff, J., Parkhill, J., Dougan, G., & Petrovska, L. (2011) · BMC Microbiology · doi:10.1186/1471-2180-11-7 · Cited by 727 · see citing works
Lepage, P., Häsler, R., Spehlmann, M. E., Rehman, A., Žvirblienė, A., Begun, A., Ott, S. J., Kupčinskas, L., Dore, J. M., Raedler, A., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.04.011 · Cited by 592 · see citing works
The Gut Microbiota in the Pathogenesis and Therapeutics of Inflammatory Bowel Disease
Zuo, T., & Ng, S. C. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02247 · Cited by 590 · see citing works
Antibiotic therapy in inflammatory bowel disease: A systematic review and meta-analysis
Khan, K. J., Ullman, T. A., Ford, A. C., Abreu, M. T., Abadir, A., Marshall, J. K., Talley, N. J., & Moayyedi, P. (2011) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.72 · Cited by 569 · see citing works
Intestinal microbiota in health and disease: Role of bifidobacteria in gut homeostasis
Tojo, R. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i41.15163 · Cited by 533 · see citing works
Geirnaert, A., Calatayud, M., Grootaert, C., Laukens, D., Devriese, S., Smagghe, G. J., Vos, M. D., Boon, N., & de Wiele, T. V. (2017) · Scientific Reports · doi:10.1038/s41598-017-11734-8 · Cited by 452 · see citing works
The Commensal Microbiota and Enteropathogens in the Pathogenesis of Inflammatory Bowel Diseases
Chassaing, B., & Darfeuille–Michaud, A. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.01.054 · Cited by 443 · see citing works
Role of priority effects in the early-life assembly of the gut microbiota
Sprockett, D., Fukami, T., & Relman, D. A. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.173 · Cited by 419 · see citing works
Microbes and the gut‐brain axis
Bercik, P., Collins, S. M., & Verdu, E. F. (2012) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2012.01906.x · Cited by 417 · see citing works
RETRACTED ARTICLE: Role of the gut microbiome in chronic diseases: a narrative review
Vijay, A., & Valdes, A. M. (2022) · European Journal of Clinical Nutrition · doi:10.1038/s41430-021-00991-6 · Cited by 361 · see citing works
RetractedImplication of Intestinal Barrier Dysfunction in Gut Dysbiosis and Diseases
Stolfi, C., Maresca, C., Monteleone, G., & Laudisi, F. (2022) · Biomedicines · doi:10.3390/biomedicines10020289 · Cited by 353 · see citing works
Toll-like receptors in inflammatory bowel diseases: A decade later
Cario, E. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21282 · Cited by 339 · see citing works
Gut microbiota in ulcerative colitis: insights on pathogenesis and treatment
Guo, X. Y., Liu, X. J., & Hao, J. Y. (2020) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12849 · Cited by 340 · see citing works
Packey, C. D., & Sartor, R. B. (2009) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e32832a8a5d · Cited by 319 · see citing works
Utilisation of Mucin Glycans by the Human Gut Symbiont Ruminococcus gnavus Is Strain-Dependent
Crost, E. H., Tailford, L. E., Gall, G. L., Fons, M., Henrissat, B., & Juge, N. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076341 · Cited by 315 · see citing works
Temporal Stability in Chronic Wound Microbiota Is Associated With Poor Healing
Loesche, M. A., Gardner, S. E., Kalan, L., Horwinski, J., Zheng, Q., Hodkinson, B. P., Tyldsley, A. S., Franciscus, C. L., Hillis, S. L., Mehta, S. D., et al. (2016) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.08.009 · Cited by 305 · see citing works
MUC2 and related bacterial factors: Therapeutic targets for ulcerative colitis
Yao, D., Dai, W., Dong, M., Dai, C., & Wu, S. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103751 · Cited by 301 · see citing works
Alterations in the gut microbiome of children with severe ulcerative colitis
Michail, S. K., Durbin, M. D., Turner, D., Griffiths, A. M., Mack, D. R., Hyams, J., LeLeiko, N. S., Kenche, H., Stolfi, A., & Wine, E. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.22860 · Cited by 283 · see citing works
Relationships Between Vitamin D, Gut Microbiome, and Systemic Autoimmunity
Yamamoto, E. A., & Jørgensen, T. N. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2019.03141 · Cited by 265 · see citing works
Varela, E., Manichanh, C., Gallart, M., Torrejón, A., Borruel, N., Casellas, F., Guarner, F., & Antolı́n, M. (2013) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12365 · Cited by 249 · see citing works
Self-citationJonkers, D., Penders, J., Masclee, A., & Pierik, M. (2012) · Drugs · doi:10.2165/11632710-000000000-00000 · Cited by 240 · see citing works
The gut microbiota in conventional and serrated precursors of colorectal cancer
Peters, B. A., Dominianni, C., Shapiro, J. A., Church, T. R., Wu, J., Miller, G., Yuen, E., Freiman, H. J., Lustbader, I., Salik, J., et al. (2016) · Microbiome · doi:10.1186/s40168-016-0218-6 · Cited by 230 · see citing works
Ulcerative colitis and irritable bowel patients exhibit distinct abnormalities of the gut microbiota
Noor, S. O., Ridgway, K., Scovell, L., Kemsley, E. K., Lund, E. K., Jamieson, C., Johnson, I. T., & Narbad, A. (2010) · BMC Gastroenterology · doi:10.1186/1471-230x-10-134 · Cited by 227 · see citing works
The Cutaneous Microbiome and Wounds: New Molecular Targets to Promote Wound Healing
Johnson, T. R., Gómez, B. I., McIntyre, M. K., Dubick, M. A., Christy, R. J., Nicholson, S. E., & Burmeister, D. M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092699 · Cited by 213 · see citing works
The intestinal microbiota and its role in human health and disease
Kataoka, K. (2016) · The Journal of Medical Investigation · doi:10.2152/jmi.63.27 · Cited by 214 · see citing works
Serological Antibodies in Inflammatory Bowel Disease: A Systematic Review
Prideaux, L., Cruz, P. P. D., Ng, S. C., & Kamm, M. A. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21903 · Cited by 209 · see citing works
The involvement of gut microbiota in inflammatory bowel disease pathogenesis: Potential for therapy
Cammarota, G., Ianiro, G., Cianci, R., Bibbò, S., Gasbarrini, A., & Currò, D. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.12.006 · Cited by 180 · see citing works
Intestinal microbiota, probiotics and prebiotics in inflammatory bowel disease
Orel, R. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i33.11505 · Cited by 177 · see citing works
Aldars‐García, L., Chaparro, M., & Gisbert, J. P. (2021) · Microorganisms · doi:10.3390/microorganisms9050977 · Cited by 177 · see citing works
Gut microbiota, the pharmabiotics they produce and host health
Patterson, E., Cryan, J. F., Fitzgerald, G. F., Ross, R. P., Dinan, T. G., & Stanton, C. (2014) · Proceedings of The Nutrition Society · doi:10.1017/s0029665114001426 · Cited by 165 · see citing works
Intestinal microbiota: A source of novel biomarkers in inflammatory bowel diseases?
Berry, D., & Reinisch, W. (2013) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2013.03.005 · Cited by 155 · see citing works
Reduced Diversity and Imbalance of Fecal Microbiota in Patients with Ulcerative Colitis
Nemoto, H., Kataoka, K., Ishikawa, H., Ikata, K., Arimochi, H., Iwasaki, T., Ohnishi, Y., Kuwahara, T., & Yasutomo, K. (2012) · Digestive Diseases and Sciences · doi:10.1007/s10620-012-2236-y · Cited by 152 · see citing works
Kasai, C., Sugimoto, K., Moritani, I., Tanaka, J., Oya, Y., Inoue, H., Tameda, M., Shiraki, K., Ito, M., Takei, Y., et al. (2015) · Oncology Reports · doi:10.3892/or.2015.4398 · Cited by 130 · see citing works
Garg, M., Hendy, P., Ding, N. S., Shaw, S., Hold, G. L., & Hart, A. L. (2018) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjy052 · Cited by 128 · see citing works
Liu, Z., Liu, F., Wang, W., Sun, C., Gao, D. M., Ma, J., Hussain, M. A., Xu, C., Jiang, Z., & Hou, J. (2020) · Food & Function · doi:10.1039/c9fo02992c · Cited by 124 · see citing works
Dysbiosis in the Gut Microbiota in Patients with Inflammatory Bowel Disease during Remission
Pisani, A., Rausch, P., Bang, C., Ellul, S., Tabone, T., Cordina, C. M., Zahra, G., Franke, A., & Ellul, P. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.00616-22 · Cited by 120 · see citing works
Duytschaever, G., Huys, G., Bekaert, M., Boulanger, L., De Boeck, K., & Vandamme, P. (2011) · Applied and Environmental Microbiology · doi:10.1128/aem.05933-11 · Cited by 114 · see citing works
Immune aspects of the pathogenesis of inflammatory bowel disease
Hisamatsu, T., Kanai∥, T., Mikami, Y., Yoneno∥, K., Matsuoka, K., & Hibi∥, T. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.10.008 · Cited by 116 · see citing works
Gulamhusein, A. F., Eaton, J. E., Tabibian, J. H., Atkinson, E. J., Juran, B. D., & Lazaridis, K. N. (2016) · The American Journal of Gastroenterology · doi:10.1038/ajg.2016.55 · Cited by 115 · see citing works
Intestinal microbiota and ulcerative colitis
Ohkusa, T., & Koido, S. (2015) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2015.07.010 · Cited by 113 · see citing works
Rethinking Diet to Aid Human–Microbe Symbiosis
Derrien, M., & Veiga, P. (2016) · Trends in Microbiology · doi:10.1016/j.tim.2016.09.011 · Cited by 112 · see citing works
Characterization of oral and gut microbiome temporal variability in hospitalized cancer patients
Galloway-Peña, J., Smith, D. P., Sahasrabhojane, P. V., Wadsworth, W. D., Fellman, B. M., Ajami, N. J., Shpall, E. J., Daver, N. G., Guindani, M., Petrosino, J. F., et al. (2017) · Genome Medicine · doi:10.1186/s13073-017-0409-1 · Cited by 112 · see citing works
Kong, G., Ellul, S., Narayana, V. K., Kanojia, K., Tran, H., Li, S., Renoir, T., Cao, K. L., & Hannan, A. J. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105199 · Cited by 110 · see citing works
Shobar, R., Velineni, S., Keshavarzian, A., Swanson, G. R., DeMeo, M. T., Melson, J. E., Losurdo, J., Engen, P. A., Sun, Y., Koenig, L., et al. (2016) · Clinical and Translational Gastroenterology · doi:10.1038/ctg.2015.54 · Cited by 108 · see citing works
Constante, M., Fragoso, G., Lupien‐Meilleur, J., Calvé, A., & Santos, M. M. (2017) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000001089 · Cited by 107 · see citing works
Walujkar, S. A., Dhotre, D., Marathe, N., Lawate, P., Bharadwaj, R., & Shouche, Y. (2014) · Gut Pathogens · doi:10.1186/1757-4749-6-22 · Cited by 110 · see citing works
Zheng, H., Chen, M., Li, Y., Wang, Y., Lin, W., Liao, Z., Wang, M., Ma, F., Liao, Q., & Xie, Z. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01703 · Cited by 102 · see citing works
Sivignon, A., de Vallée, A., Barnich, N., Denizot, J., Darcha, C., Pignède, G., Vandekerckove, P., & Darfeuille–Michaud, A. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000280 · Cited by 99 · see citing works
Characterization of the Gastrointestinal Microbiota in Health and Inflammatory Bowel Disease
Cruz, P. P. D., Prideaux, L., Wagner, J., Ng, S. C., McSweeney, C. S., Kirkwood, C. D., Morrison, M., & Kamm, M. A. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21751 · Cited by 95 · see citing works
Mechanisms of Microbe–Host Interaction in Crohn’s Disease: Dysbiosis vs. Pathobiont Selection
Buttó, L. F., Schaubeck, M., & Haller, D. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00555 · Cited by 92 · see citing works
Prideaux, L., Kang, S., Wagner, J., Buckley, M. J., Mahar, J. E., Cruz, P. P. D., Wen, Z., Chen, L., Xia, B., van Langenberg, D. R., et al. (2013) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000435759.05577.12 · Cited by 90 · see citing works
Beneficial Effects of Fecal Microbiota Transplantation on Ulcerative Colitis in Mice
Tian, Z., Liu, J., Liao, M., Li, W., Zou, J., Han, X., Kuang, M., Shen, W., & Li, H. (2016) · Digestive Diseases and Sciences · doi:10.1007/s10620-016-4060-2 · Cited by 82 · see citing works
Probiotics in the Treatment of Inflammatory Bowel Disease
Guandalini, S., & Sansotta, N. (2019) · Advances in experimental medicine and biology · doi:10.1007/5584_2018_319 · Cited by 70 · see citing works
Fecal microbiota in pouchitis and ulcerative colitis
Li, K., Wang, J.-L., Wei, J., Gao, S.-Y., Zhang, Y., Wang, L.-T., & Liu, G. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i40.8929 · Cited by 68 · see citing works
Dupaul-Chicoine, J., Dagenais, M., & Saleh, M. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e31828dcac7 · Cited by 67 · see citing works
Khalil, N. A., Walton, G., Gibson, G. R., Tuohy, K. M., & Andrews, S. C. (2013) · International Journal of Food Sciences and Nutrition · doi:10.3109/09637486.2013.825700 · Cited by 66 · see citing works
Bugging inflammation: role of the gut microbiota
Shen, S., & Wong, C. H. Y. (2016) · Clinical & Translational Immunology · doi:10.1038/cti.2016.12 · Cited by 66 · see citing works
Cai, Y., Liu, W., Lin, Y., Zhang, S., Zou, B., Xiao, D., Lin, L., Zhong, Y., Zheng, H., Liao, Q., et al. (2018) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.14583 · Cited by 64 · see citing works
Colitis-Induced Microbial Perturbation Promotes Postinflammatory Visceral Hypersensitivity
Esquerre, N., Basso, L., Defaye, M., Vicentini, F., Cluny, N. L., Bihan, D. G., Hirota, S. A., Schick, A., Jijon, H. B., Lewis, I. A., et al. (2020) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2020.04.003 · Cited by 65 · see citing works
Highlighting the Relevance of Gut Microbiota Manipulation in Inflammatory Bowel Disease
Pavel, F. M., Vesa, C. M., Gheorghe, G., Diaconu, C. C., Stoicescu, M., Munteanu, M. A., Babeş, E. E., Ţiţ, D. M., Toma, M. M., & BUNGAU, S. G. (2021) · Diagnostics · doi:10.3390/diagnostics11061090 · Cited by 64 · see citing works
Bacterial Flora in Inflammatory Bowel Disease
Marteau, P. R. (2009) · Digestive Diseases · doi:10.1159/000268128 · Cited by 63 · see citing works
Mechanisms of Colonization Resistance Against Clostridioides difficile
Pike, C. M., & Theriot, C. M. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa408 · Cited by 61 · see citing works
Role of Microbiome and Antibiotics in Autoimmune Diseases
Vangoitsenhoven, R., & Cresci, G. (2020) · Nutrition in Clinical Practice · doi:10.1002/ncp.10489 · Cited by 60 · see citing works
The human intestinal microbiota
Dore, J. M., & Corthier, G. (2010) · Gastroentérologie Clinique et Biologique · doi:10.1016/s0399-8320(10)70015-4 · Cited by 57 · see citing works
Du, Z., Hudcovic, T., Mrázek, J., Kozáková, H., Šrůtková, D., Schwarzer, M., Tlaskalová‐Hogenová, H., Kostovčík, M., & Kverka, M. (2015) · Gut Pathogens · doi:10.1186/s13099-015-0080-2 · Cited by 54 · see citing works
Analysis of Gut Microbiome and Diet Modification in Patients with Crohn’s Disease
Walters, S. S. (2014) · SOJ Microbiology & Infectious Diseases · doi:10.15226/sojmid/2/3/00122 · Cited by 53 · see citing works
Compositional Changes in the Gut Mucus Microbiota Precede the Onset of Colitis-Induced Inflammation
Glymenaki, M., Singh, G., Brass, A., Warhurst, G., McBain, A. J., Else, K. J., & Cruickshank, S. M. (2017) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000001118 · Cited by 53 · see citing works
Yılmaz, B., Spalinger, M. R., Biedermann, L., Franc, Y., Fournier, N., Rossel, J., Juillerat, P., Rogler, G., Macpherson, A. J., & Scharl, M. M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0199664 · Cited by 53 · see citing works
Ellermann, M., Gharaibeh, R. Z., Maharshak, N., Peréz-Chanona, E., Jobin, C., Carroll, I. M., Arthur, J. C., Plevy, S. E., Fodor, A. A., Brouwer, C., et al. (2019) · Gut Microbes · doi:10.1080/19490976.2019.1599794 · Cited by 52 · see citing works
Enteric microbiota leads to new therapeutic strategies for ulcerative colitis
Chen, W.-X. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i42.15657 · Cited by 51 · see citing works
The role of inflammation in temporal shifts in the inflammatory bowel disease mucosal microbiome
Kiely, C. J., Pavli, P., & O'Brien, C. L. (2018) · Gut Microbes · doi:10.1080/19490976.2018.1448742 · Cited by 47 · see citing works
Yeom, Y., Kim, B. S., Kim, S.-J., & Kim, Y. (2016) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-016-1456-7 · Cited by 44 · see citing works
The Multifactorial Etiopathogeneses Interplay of Inflammatory Bowel Disease: An Overview
M’Koma, A. E. (2018) · Gastrointestinal Disorders · doi:10.3390/gidisord1010007 · Cited by 46 · see citing works
Thomann, A., Mak, J. W. Y., Zhang, J., Wüstenberg, T., Ebert, M. P., Sung, J. J. �., Bernstein, C. N., Reindl, W., & Ng, S. C. (2020) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15787 · Cited by 44 · see citing works
Al-Amrah, H., Saadah, O. I., Mosli, M. H., Annese, V., Al-Hindi, R. R., Edris, S., Alshehri, D., Alatawi, H. A., Alatawy, M., & Bahieldin, A. (2023) · Saudi Journal of Gastroenterology · doi:10.4103/sjg.sjg_368_22 · Cited by 41 · see citing works
Bacteria in the pathogenesis of inflammatory bowel disease
Flanagan, P. K., Campbell, B. J., & Rhodes, J. M. (2011) · Biochemical Society Transactions · doi:10.1042/bst0391067 · Cited by 41 · see citing works
Influences of Intestinal Bacteria in Human Inflammatory Bowel Disease
Vanderploeg, R., Panaccione, R., Ghosh, S. K., & Rioux, K. P. (2010) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2010.07.008 · Cited by 39 · see citing works
Jalanka, J., Cheng, J., Hiippala, K., Ritari, J., Salojärvi, J., Ruuska, T., Kalliomäki, M., & Satokari, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176044 · Cited by 37 · see citing works
Satokari, R. M. (2014) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2014.966320 · Cited by 39 · see citing works
Prebiotics and probiotics in irritable bowel syndrome and inflammatory bowel disease in children
Guandalini, S., Cernat, E., & Moscoso, D. I. (2014) · Beneficial Microbes · doi:10.3920/bm2014.0067 · Cited by 36 · see citing works
Lacroix, V., Cassard, A., Mas, E., & Barreau, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222011255 · Cited by 36 · see citing works
The evidence for fungus in Crohn’s disease pathogenesis
Miyoshi, J., Sofia, M., & Pierre, J. F. (2018) · Clinical Journal of Gastroenterology · doi:10.1007/s12328-018-0886-9 · Cited by 35 · see citing works
Bacteria as Trigger for Chronic Gastrointestinal Disorders
Marteau, P. R., & Chaput, U. (2011) · Digestive Diseases · doi:10.1159/000323879 · Cited by 34 · see citing works
Assadsangabi, A., Evans, C. A., Corfe, B. M., & Lobo, A. (2019) · Gastroenterology Research and Practice · doi:10.1155/2019/1426954 · Cited by 35 · see citing works
Reciprocal interaction of diet and microbiome in inflammatory bowel diseases
Schaubeck, M., & Haller, D. (2015) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000216 · Cited by 32 · see citing works
Emerging Nanotechnologies and Microbiome Engineering for the Treatment of Inflammatory Bowel Disease
Abed, O. A., Attlassy, Y., Xu, J., Han, K., & Moon, J. J. (2022) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.2c00222 · Cited by 34 · see citing works
van Schewick, C. M., Nöltner, C., Abel, S., Burns, S. O., Workman, S., Symes, A., Guzman, D., Proietti, M., Bulashevska, A., Moreira, F., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01654 · Cited by 32 · see citing works
- Authors
- Martinez, C., Antolin, M., Santos, J., Torrejon, A., Casellas, F., Borruel, N., Guarner, F., & Malagelada, J.-R.
- Affiliations
- Vall d'Hebron Hospital Universitari (ES)
- Instituto de Salud Carlos III (ES)
- Venue
- The American Journal of Gastroenterology
- Published
- 2008-03
- Volume
- 103
- Issue
- 3
- Pages
- 643-648
- ISSN
- 0002-9270 (ISSN-L)
- 1572-0241
- OpenAlex
- W1967499190
- Cited by
- 208
- References
- 25
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 12 · 2023: 5 · 2022: 12 · 2021: 14 · 2020: 17 · 2019: 9 · 2018: 17 · 2017: 12 · 2016: 19 · 2015: 11 · 2014: 18 · 2013: 14 · 2012: 10
- FWCI
- 4.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The American Journal of Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Generalitat de Catalunya
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Inflammatory Bowel Disease
- Health Sciences › Medicine › Epidemiology › Microscopic Colitis
- Keywords
- ulcerative colitis, fecal microbiota, clinical remission, microbial diversity, temporal stability, 16S rRNA gene, 5-aminosalicylic acid, inflammatory bowel disease, host specificity, microbiota dynamics
- MeSH terms
- Adult, Colitis, Ulcerative, DNA, Bacterial, Electrophoresis, Polyacrylamide Gel, Feces, Female, Humans, Male, Middle Aged, Remission Induction, Polymerase Chain Reaction, DNA Fingerprinting
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review